HEADER TRANSFERASE 03-MAY-18 6DBK TITLE TYK2 WITH COMPOUND 8 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TYK2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF21 KEYWDS KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR F.F.VAJDOS REVDAT 2 07-NOV-18 6DBK 1 JRNL REVDAT 1 29-AUG-18 6DBK 0 JRNL AUTH A.FENSOME,C.M.AMBLER,E.ARNOLD,M.E.BANKER,M.F.BROWN, JRNL AUTH 2 J.CHRENCIK,J.D.CLARK,M.E.DOWTY,I.V.EFREMOV,A.FLICK, JRNL AUTH 3 B.S.GERSTENBERGER,A.GOPALSAMY,M.M.HAYWARD,M.HEGEN, JRNL AUTH 4 B.D.HOLLINGSHEAD,J.JUSSIF,J.D.KNAFELS,D.C.LIMBURG,D.LIN, JRNL AUTH 5 T.H.LIN,B.S.PIERCE,E.SAIAH,R.SHARMA,P.T.SYMANOWICZ, JRNL AUTH 6 J.B.TELLIEZ,J.I.TRUJILLO,F.F.VAJDOS,F.VINCENT,Z.K.WAN, JRNL AUTH 7 L.XING,X.YANG,X.YANG,L.ZHANG JRNL TITL DUAL INHIBITION OF TYK2 AND JAK1 FOR THE TREATMENT OF JRNL TITL 2 AUTOIMMUNE DISEASES: DISCOVERY OF (( JRNL TITL 3 S)-2,2-DIFLUOROCYCLOPROPYL)((1 R,5 S)-3-(2-((1-METHYL-1 JRNL TITL 4 H-PYRAZOL-4-YL)AMINO)PYRIMIDIN-4-YL)-3, JRNL TITL 5 8-DIAZABICYCLO[3.2.1]OCTAN-8-YL)METHANONE (PF-06700841). JRNL REF J. MED. CHEM. V. 61 8597 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30113844 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00917 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 19007 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 970 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.11 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.25 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2619 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2295 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2485 REMARK 3 BIN R VALUE (WORKING SET) : 0.2285 REMARK 3 BIN FREE R VALUE : 0.2486 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.12 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 134 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2343 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 157 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.38 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.59110 REMARK 3 B22 (A**2) : 7.41320 REMARK 3 B33 (A**2) : -6.82210 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.255 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.230 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.186 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.216 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.182 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2462 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3359 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 847 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 55 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 378 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2462 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 295 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2895 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.08 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.61 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DBK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1000234332. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-OCT-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19090 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 103.026 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05900 REMARK 200 FOR THE DATA SET : 17.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.33600 REMARK 200 R SYM FOR SHELL (I) : 0.33600 REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.89 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 5.5, 0.25 M NACL, 10 REMARK 280 MM TCEP, 27-33% PEG-3350, PH 8.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.24150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.51300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.56950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.51300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.24150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.56950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 865 REMARK 465 ALA A 866 REMARK 465 HIS A 867 REMARK 465 HIS A 868 REMARK 465 HIS A 869 REMARK 465 HIS A 870 REMARK 465 HIS A 871 REMARK 465 HIS A 872 REMARK 465 HIS A 873 REMARK 465 HIS A 874 REMARK 465 HIS A 875 REMARK 465 HIS A 876 REMARK 465 GLY A 877 REMARK 465 ALA A 878 REMARK 465 LEU A 879 REMARK 465 GLU A 880 REMARK 465 VAL A 881 REMARK 465 LEU A 882 REMARK 465 PHE A 883 REMARK 465 GLN A 884 REMARK 465 GLY A 885 REMARK 465 PRO A 886 REMARK 465 GLY A 887 REMARK 465 ASP A 888 REMARK 465 GLN A 1179 REMARK 465 ALA A 1180 REMARK 465 PRO A 1181 REMARK 465 SER A 1182 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 908 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 917 79.95 -119.07 REMARK 500 PRO A 918 70.00 -69.60 REMARK 500 THR A 919 -94.29 173.76 REMARK 500 ASN A 920 -5.87 157.02 REMARK 500 ASP A 921 -168.06 -74.91 REMARK 500 THR A 923 33.00 -81.90 REMARK 500 ASP A 968 75.91 -105.21 REMARK 500 ALA A 972 3.43 59.98 REMARK 500 SER A 973 -160.15 -113.08 REMARK 500 ARG A1022 -2.15 72.46 REMARK 500 ASP A1023 36.40 -145.41 REMARK 500 ASP A1034 -13.05 -46.58 REMARK 500 GLU A1050 -56.07 -29.67 REMARK 500 ARG A1058 78.89 63.62 REMARK 500 GLU A1059 125.27 -39.98 REMARK 500 ALA A1115 42.00 -104.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A4257 DISTANCE = 7.34 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G5D A 4000 DBREF 6DBK A 888 1182 UNP P29597 TYK2_HUMAN 888 1182 SEQADV 6DBK MET A 865 UNP P29597 EXPRESSION TAG SEQADV 6DBK ALA A 866 UNP P29597 EXPRESSION TAG SEQADV 6DBK HIS A 867 UNP P29597 EXPRESSION TAG SEQADV 6DBK HIS A 868 UNP P29597 EXPRESSION TAG SEQADV 6DBK HIS A 869 UNP P29597 EXPRESSION TAG SEQADV 6DBK HIS A 870 UNP P29597 EXPRESSION TAG SEQADV 6DBK HIS A 871 UNP P29597 EXPRESSION TAG SEQADV 6DBK HIS A 872 UNP P29597 EXPRESSION TAG SEQADV 6DBK HIS A 873 UNP P29597 EXPRESSION TAG SEQADV 6DBK HIS A 874 UNP P29597 EXPRESSION TAG SEQADV 6DBK HIS A 875 UNP P29597 EXPRESSION TAG SEQADV 6DBK HIS A 876 UNP P29597 EXPRESSION TAG SEQADV 6DBK GLY A 877 UNP P29597 EXPRESSION TAG SEQADV 6DBK ALA A 878 UNP P29597 EXPRESSION TAG SEQADV 6DBK LEU A 879 UNP P29597 EXPRESSION TAG SEQADV 6DBK GLU A 880 UNP P29597 EXPRESSION TAG SEQADV 6DBK VAL A 881 UNP P29597 EXPRESSION TAG SEQADV 6DBK LEU A 882 UNP P29597 EXPRESSION TAG SEQADV 6DBK PHE A 883 UNP P29597 EXPRESSION TAG SEQADV 6DBK GLN A 884 UNP P29597 EXPRESSION TAG SEQADV 6DBK GLY A 885 UNP P29597 EXPRESSION TAG SEQADV 6DBK PRO A 886 UNP P29597 EXPRESSION TAG SEQADV 6DBK GLY A 887 UNP P29597 EXPRESSION TAG SEQADV 6DBK ALA A 936 UNP P29597 CYS 936 ENGINEERED MUTATION SEQADV 6DBK ALA A 969 UNP P29597 GLN 969 ENGINEERED MUTATION SEQADV 6DBK ALA A 971 UNP P29597 GLU 971 ENGINEERED MUTATION SEQADV 6DBK ALA A 972 UNP P29597 LYS 972 ENGINEERED MUTATION SEQADV 6DBK SER A 1016 UNP P29597 ALA 1016 CONFLICT SEQADV 6DBK ALA A 1142 UNP P29597 CYS 1142 ENGINEERED MUTATION SEQRES 1 A 318 MET ALA HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS GLY SEQRES 2 A 318 ALA LEU GLU VAL LEU PHE GLN GLY PRO GLY ASP PRO THR SEQRES 3 A 318 VAL PHE HIS LYS ARG TYR LEU LYS LYS ILE ARG ASP LEU SEQRES 4 A 318 GLY GLU GLY HIS PHE GLY LYS VAL SER LEU TYR CYS TYR SEQRES 5 A 318 ASP PRO THR ASN ASP GLY THR GLY GLU MET VAL ALA VAL SEQRES 6 A 318 LYS ALA LEU LYS ALA ASP ALA GLY PRO GLN HIS ARG SER SEQRES 7 A 318 GLY TRP LYS GLN GLU ILE ASP ILE LEU ARG THR LEU TYR SEQRES 8 A 318 HIS GLU HIS ILE ILE LYS TYR LYS GLY CYS CYS GLU ASP SEQRES 9 A 318 ALA GLY ALA ALA SER LEU GLN LEU VAL MET GLU TYR VAL SEQRES 10 A 318 PRO LEU GLY SER LEU ARG ASP TYR LEU PRO ARG HIS SER SEQRES 11 A 318 ILE GLY LEU ALA GLN LEU LEU LEU PHE ALA GLN GLN ILE SEQRES 12 A 318 CYS GLU GLY MET ALA TYR LEU HIS SER GLN HIS TYR ILE SEQRES 13 A 318 HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU LEU ASP ASN SEQRES 14 A 318 ASP ARG LEU VAL LYS ILE GLY ASP PHE GLY LEU ALA LYS SEQRES 15 A 318 ALA VAL PRO GLU GLY HIS GLU PTR TYR ARG VAL ARG GLU SEQRES 16 A 318 ASP GLY ASP SER PRO VAL PHE TRP TYR ALA PRO GLU CYS SEQRES 17 A 318 LEU LYS GLU TYR LYS PHE TYR TYR ALA SER ASP VAL TRP SEQRES 18 A 318 SER PHE GLY VAL THR LEU TYR GLU LEU LEU THR HIS CYS SEQRES 19 A 318 ASP SER SER GLN SER PRO PRO THR LYS PHE LEU GLU LEU SEQRES 20 A 318 ILE GLY ILE ALA GLN GLY GLN MET THR VAL LEU ARG LEU SEQRES 21 A 318 THR GLU LEU LEU GLU ARG GLY GLU ARG LEU PRO ARG PRO SEQRES 22 A 318 ASP LYS CYS PRO ALA GLU VAL TYR HIS LEU MET LYS ASN SEQRES 23 A 318 CYS TRP GLU THR GLU ALA SER PHE ARG PRO THR PHE GLU SEQRES 24 A 318 ASN LEU ILE PRO ILE LEU LYS THR VAL HIS GLU LYS TYR SEQRES 25 A 318 GLN GLY GLN ALA PRO SER MODRES 6DBK PTR A 1054 TYR MODIFIED RESIDUE HET PTR A1054 16 HET G5D A4000 53 HETNAM PTR O-PHOSPHOTYROSINE HETNAM G5D 4-({4-[(1S,4S)-5-(CYANOACETYL)-2,5- HETNAM 2 G5D DIAZABICYCLO[2.2.1]HEPTAN-2-YL]PYRIMIDIN-2-YL}AMINO)- HETNAM 3 G5D N-ETHYLBENZAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR C9 H12 N O6 P FORMUL 2 G5D C21 H23 N7 O2 FORMUL 3 HOH *157(H2 O) HELIX 1 AA1 HIS A 893 ARG A 895 5 3 HELIX 2 AA2 GLY A 937 LEU A 954 1 18 HELIX 3 AA3 SER A 985 LEU A 990 1 6 HELIX 4 AA4 PRO A 991 HIS A 993 5 3 HELIX 5 AA5 GLY A 996 GLN A 1017 1 22 HELIX 6 AA6 ALA A 1025 ARG A 1027 5 3 HELIX 7 AA7 PRO A 1064 TYR A 1068 5 5 HELIX 8 AA8 ALA A 1069 GLU A 1075 1 7 HELIX 9 AA9 TYR A 1080 THR A 1096 1 17 HELIX 10 AB1 ASP A 1099 GLN A 1102 5 4 HELIX 11 AB2 SER A 1103 GLY A 1113 1 11 HELIX 12 AB3 GLN A 1116 GLN A 1118 5 3 HELIX 13 AB4 MET A 1119 ARG A 1130 1 12 HELIX 14 AB5 PRO A 1141 TRP A 1152 1 12 HELIX 15 AB6 GLU A 1155 ARG A 1159 5 5 HELIX 16 AB7 THR A 1161 GLY A 1178 1 18 SHEET 1 AA1 5 LEU A 897 GLU A 905 0 SHEET 2 AA1 5 GLY A 909 TYR A 916 -1 O LEU A 913 N ARG A 901 SHEET 3 AA1 5 GLU A 925 LEU A 932 -1 O GLU A 925 N TYR A 916 SHEET 4 AA1 5 LEU A 974 GLU A 979 -1 O LEU A 976 N LYS A 930 SHEET 5 AA1 5 TYR A 962 GLU A 967 -1 N LYS A 963 O VAL A 977 SHEET 1 AA2 2 TYR A1019 ILE A1020 0 SHEET 2 AA2 2 LYS A1046 ALA A1047 -1 O LYS A1046 N ILE A1020 SHEET 1 AA3 2 VAL A1029 ASN A1033 0 SHEET 2 AA3 2 LEU A1036 ILE A1039 -1 O LYS A1038 N LEU A1030 SHEET 1 AA4 2 PTR A1054 ARG A1056 0 SHEET 2 AA4 2 LYS A1077 TYR A1079 -1 O PHE A1078 N TYR A1055 LINK C GLU A1053 N PTR A1054 1555 1555 1.33 LINK C PTR A1054 N TYR A1055 1555 1555 1.33 SITE 1 AC1 20 GLY A 904 GLU A 905 GLY A 906 GLY A 909 SITE 2 AC1 20 LYS A 910 VAL A 911 ALA A 928 LYS A 930 SITE 3 AC1 20 ILE A 960 GLU A 979 TYR A 980 VAL A 981 SITE 4 AC1 20 PRO A 982 GLY A 984 ASP A 988 ARG A1027 SITE 5 AC1 20 LEU A1030 GLY A1040 ASP A1041 ARG A1123 CRYST1 36.483 73.139 103.026 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027410 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013673 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009706 0.00000